Diabetic Nephropathy Market Size 2021: Top Countries Data, Growth Factors, Global demand Analysis, Opportunities and Forecast To 2024 | Says Kenneth Research

Kenneth Research has recently added a report titled Diabetic Nephropathy market in its storehouse of market research reports. The report provides a detailed insight into the market scenario on the basis of the market size and volume for the forecast period, i.e., 2021-2024. Diabetic Nephropathy market is further anticipated to grow with a CAGR of  5.9% during the forecast period. Factors such as the growing advancements in the development of novel drugs, coupled with the growing health infrastructure in several nations worldwide are anticipated to drive the growth of the market in the coming years. Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

“Final Report will add the analysis of the impact of COVID-19 on this industry.”

Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024; growing at a CAGR of 5.9% from 2016 to 2024. Diabetic nephropathy involves damage of kidney due to the presence of diabetic mellitus. It is a progressive kidney disease majorly caused due to occurrence if persistent proteinuria in diabetic patients. It affects people suffering from type1 and type2 diabetes. Diabetic nephropathy comprises of 5 stages, with the final being end-stage renal disease (ESRD). Patient affected by diabetic nephropathy shows symptoms of weakness, vomiting, leg swelling, high blood pressure, nausea, high albumin secretion in urine, and high level of blood urea nitrogen. Diabetic nephropathy affects around 40% of people suffering from type1 and type2 diabetics. Moreover, it is also capable of increases the chances of cardiovascular mortality. Regular awareness programs are being initiated by various government and NGOs which aids in inculcating the knowledge of preventive measures and treatments among diabetes population.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10325506

The global diabetic nephropathy market is driven by rising obesity and diabetes among population, rise in number of people suffering from kidney diseases, growing awareness and rising investments in research and development. Though, longer duration for drug approvals and government regulations may limit the growth in forecasted period. Additionally, rising awareness and demand for combination therapies might provide opportunities for the market.

The global diabetic nephropathy market is classified into mode of treatment and geography. Mode of treatment is bifurcated into drug modifying therapies (renin inhibitors, connective tissue growth factor inhibitor (CTGF), angiotensin-converting enzyme (ACE) inhibitor, angiotensin receptor blockers (ARBs), monocyte chemoattractant proteins (MCP) inhibitors, diuretics, G protein-coupled receptors (GPCRs), calcium channel blockers (CCBs), antioxidant inflammation modulator (AIM), endothelin-A receptors antagonist (ETAR), and others) and others.

By geography, the market has been bifurcated into North America, Europe, Asia-Pacific, and Rest of the World (RoW). The U.S., Canada, Mexico are covered under North America wherein Europe covers UK, Germany, France Italy, and others. Asia-Pacific covers China, Japan, India, South Korea, and others. RoW covers South America, Middle East, and Africa.

Key players in the market include Mallinckrodt Pharmaceuticals, Bayer AG, Mitsubishi Tanabe Pharma Corporation, GenKyoTex S.A., Novartis AG, Eli Lilly and Company, Mesoblast Ltd., Ampio Pharmaceuticals Inc., Reata Pharmaceuticals, and ChemoCentryx Inc., among others.

The key takeaways from the report:
The report will provide a detailed analysis of Global Diabetic Nephropathy Market with respect to major segments such as mode of treatment and geography. The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024. Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
An exhaustive regional analysis of Global Diabetic Nephropathy s Market from 2015 to 2024 will be included in the report. Profile of the key players in the Global Diabetic Nephropathy Market will be provided, which include key financials, product & services, new developments and business strategies.

Scope of the Global Diabetic Nephropathy Market:
Mode of Treatment Segments
Drug Modifying Therapies
Renin Inhibitors
Connective Tissue Growth Factor Inhibitor (CTGF)
Angiotensin-Converting Enzyme (ACE) Inhibitor
Angiotensin Receptor Blockers (ARBs)
Monocyte Chemoattractant Proteins (MCP) Inhibitors
G Protein-Coupled Receptors (GPCRs)
Calcium Channel Blockers (CCBs)
Antioxidant Inflammation Modulator (AIM)
Endothelin-A Receptors Antagonist (ETAR)
Other Drug Modifying Therapies
Other Mode of Treatments

Request For Full Report:https://www.kennethresearch.com/sample-request-10325506

Geography Segments
North America
South Korea
South America
Middle East

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : Sales@kennethresearch.com

Phone: +1 313 462 0609

James Bullock is a Research Expert with a demonstrated history of working in the professional training & coaching industry. Strong professional skilled in business strategy , Strategic Planning, Research Strategy, and Marketing. also have interest in new innovations and technology

Leave a Reply